Landmark University SDG 3 (Good Health and Well-being Group), Omu-Aran, Kwara, Nigeria.
Department of Microbiology, Landmark University, PMB 1001, Omu-Aran, 251101, Nigeria.
Sci Rep. 2024 Oct 24;14(1):25222. doi: 10.1038/s41598-024-75796-1.
Salmonella Typhi is a major global concern in many low- and middle-income countries. In addition, the emergence and persistence of drug resistant strains has increased the impact of this disease. Plant metabolites have been explored traditionally and scientifically as antimicrobial agents. Thus, this study was designed to investigate the antimicrobial potential of acetone leaf fractions of H. indica against S. Typhi. Dried pulverized leaves of H. indica were extracted using cold maceration with acetone after defatting with n-hexane. The leaf extract was concentrated and subjected to column chromatography and eight bioactive fractions were identified. The fractions were characterized using gas chromatography-mass spectrometry. The fractions were evaluated for antibacterial activity against Salmonella Typhi in-vitro and in-silico. The lowest MIC was observed in fractions 20 and 21 (0.375 mg/mL) while the lowest MBC was observed in all fractions except 7, 17 and 18 (0.375 mg/mL). A ligand from fraction 8 had the highest binding affinity to Type I dehydroquinase (-3.4) and a ligand from fraction 7 had the highest binding affinity to Gyrase B (-11.2). This study concludes that the overall antimicrobial activity of the acetone leaf extract of H. indica provided evidence that it contains drug-like compounds that can be further explored as a drug candidate against S. Typhi.
伤寒沙门氏菌是许多低收入和中等收入国家的主要全球性关注问题。此外,耐药菌株的出现和持续存在增加了这种疾病的影响。植物代谢物一直被传统和科学地探索为抗菌剂。因此,本研究旨在研究印度诃子丙酮叶部分对伤寒沙门氏菌的抗菌潜力。在使用正己烷脱脂后,用丙酮对印度诃子干燥粉碎的叶子进行冷浸提取。提取液浓缩后进行柱层析,分离出 8 个生物活性馏分。使用气相色谱-质谱法对馏分进行了表征。评估了馏分对伤寒沙门氏菌的体外和体内抗菌活性。最低 MIC 观察到在馏分 20 和 21(0.375mg/mL)中,而除 7、17 和 18 外,所有馏分的最低 MBC 均为 0.375mg/mL(0.375mg/mL)。来自馏分 8 的配体对 I 型脱氢酶具有最高的结合亲和力(-3.4),而来自馏分 7 的配体对回旋酶 B 具有最高的结合亲和力(-11.2)。本研究得出的结论是,印度诃子丙酮叶提取物的整体抗菌活性提供了证据表明它含有类药性化合物,可以进一步探索作为抗伤寒沙门氏菌的候选药物。